![Nicola Heffron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicola Heffron
Sales & Marketing at ALEXION PHARMACEUTICALS, INC.
Net worth: 106 643 $ as of 30/05/2024
Network origin in Nicola Heffron first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 14 | |
10
| Subsidiary | Biotechnology | 10 |
Public Company | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nicola Heffron via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
ImClone LLC
![]() ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | General Counsel | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oxeia Biopharmaceuticals, Inc.
![]() Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Compliance Officer | |
Dana-Farber Cancer Institute, Inc.
![]() Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
University of Cambridge | College/University | Graduate Degree | |
Brandeis University | College/University | Undergraduate Degree | |
State University of New York College at Oneonta | College/University | Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Fairleigh Dickinson University | College/University | Masters Business Admin | |
Haverford College | College/University | Undergraduate Degree | |
Ramapo College of New Jersey | College/University | Undergraduate Degree | |
University of Illinois | College/University | Masters Business Admin | |
The University of Texas M.D. Anderson Cancer Center
![]() The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Corporate Officer/Principal | |
Sapienza University of Rome | College/University | Doctorate Degree | |
University of Cardiff | College/University | Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
![]() Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
James P. Wilmot Cancer Center | Corporate Officer/Principal | ||
Pfizer Pharmaceuticals, Inc.
![]() Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Roche (China) Co. Ltd. | Corporate Officer/Principal | ||
Astrazeneca Pharma Poland SP zoo | Corporate Officer/Principal | ||
SWOG
![]() SWOG Hospital/Nursing ManagementHealth Services SWOG operates cancer clinics. The non-profit company is based in San Antonio, TX. | Hospital/Nursing Management | Corporate Officer/Principal | |
Astex Pharmaceuticals, Inc.
![]() Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member | |
Università Campus Bio-Medico di Roma | College/University | Doctorate Degree | |
University of Life Sciences In Lublin | College/University | Doctorate Degree | |
The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Seton Hall University School of Law | College/University | Graduate Degree | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Celgene Cellular Therapeutics
![]() Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Pharmaceuticals: Major | Chief Operating Officer | |
Clene Nanomedicine, Inc.
![]() Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ALLOVIR, INC. | Biotechnology | Corporate Officer/Principal | |
SCOPE FLUIDICS S.A. | Medical Specialties | Director/Board Member | |
ERASCA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Servier Pharmaceuticals LLC
![]() Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer, Inc. /India/ | Corporate Officer/Principal | ||
Proskauer Rose LLC | Corporate Officer/Principal | ||
INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
Civetta Therapeutics LLC
![]() Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Civetta Therapeutics LLC develops therapeutics for cancers and other diseases. The company was founded by William Sellers and Eric Fischer and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
TREX WIND-DOWN, INC. | Pharmaceuticals: Major | Director/Board Member | |
CHIMERIC THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
New York University School of Medicine | College/University | Doctorate Degree |
Statistics
International
United States | 38 |
United Kingdom | 4 |
Poland | 4 |
Italy | 3 |
France | 2 |
Sectoral
Health Technology | 24 |
Consumer Services | 18 |
Health Services | 3 |
Electronic Technology | 2 |
Commercial Services | 2 |
Operational
Corporate Officer/Principal | 55 |
Director/Board Member | 39 |
Undergraduate Degree | 17 |
Chief Tech/Sci/R&D Officer | 15 |
Independent Dir/Board Member | 14 |
Most connected contacts
Insiders | |
---|---|
Frédéric Chéreau | 17 |
Marc Dunoyer | 16 |
William R. Sellers | 14 |
David Elkins | 13 |
Gilla Kaplan | 12 |
Justin Chakma | 9 |
Wei Lin | 9 |
Glen Frick | 8 |
Philip Gregory | 7 |
Gianluca Pirozzi | 7 |
Thomas Perone | 7 |
Steven H. Bernstein | 7 |
Jacquelyn Sumer | 6 |
Tamar Thompson | 6 |
George Matcham | 6 |
- Stock Market
- Insiders
- Nicola Heffron
- Company connections